Active, Not Recruiting
Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors
NCT05071209
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States